CXCL2 and esophageal squamous cell carcinoma: A study in esophageal squamous cell carcinoma showed that inflammation or immune-related TLR4, IL-8, IL-6, and chemokine (C-X-C motif) ligand 2 (CXCL2) were increased upon PLCE1 suppression [60].